BIOMAT Database Logo BIOMAT Database Logo

The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes. 1958

S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING

UI MeSH Term Description Entries
D011319 Primaquine An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404) Primacin,Primaquine Diphosphate,Primaquine Phosphate,Diphosphate, Primaquine,Phosphate, Primaquine
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell

Related Publications

S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING
The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes.
August 1954, The Journal of laboratory and clinical medicine,
S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING
The hemolytic effect of primaquine. XI. Decreased catalase activity in primaquine-sensitive erythrocytes.
August 1961, The Journal of laboratory and clinical medicine,
S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING
Enzymatic deficiency in primaquine-sensitive erythrocytes.
September 1956, Science (New York, N.Y.),
S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING
HEMOLYTIC EFFECT OF PRIMAQUINE. XVI. GLYOXALASE ACTIVITY OF PRIMAQUINE-SENSITIVE AND NORMAL ERYTHROCYTES.
January 1964, The Journal of laboratory and clinical medicine,
S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING
The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes.
February 1955, The Journal of laboratory and clinical medicine,
S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING
The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals.
February 1954, The Journal of laboratory and clinical medicine,
S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING
The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine.
January 1955, The Journal of laboratory and clinical medicine,
S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING
The hemolytic effect of primaquine. VIII. The effect of drug administration on parameters of primaquine sensitivity.
April 1958, The Journal of laboratory and clinical medicine,
S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING
HEMOLYTIC EFFECT OF PRIMAQUINE. XVII. HEXOKINASE ACTIVITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT AND NORMAL ERYTHROCYTES.
October 1964, The Journal of laboratory and clinical medicine,
S L SCHRIER, and R W KELLERMEYER, and P E CARSON, and C E ICKES, and A S ALVING
Certain aspects of carbohydrate and lipid metabolism in primaquine sensitive erythrocytes.
December 1961, The South African journal of medical sciences,
Copied contents to your clipboard!